entertainment -WSS

entertainment

author：leisure time 2025-10-03 00:40:06 - browse：88

The artificial womb, a device aiming to save infants born way too soon, is inching closer to being tested in humans.

The technology is close enough to reality that the Food and Drug Administration has decided to convene a two-day panel starting Tuesday to discuss how to best evaluate safety and effectiveness, as well as the ethical quandaries in running clinical trials. The second day will be closed to the public to shield trade secrets.

Several research teams are racing to build artificial placentas that replicate the uterine environment and give the very prematurely born a better shot at survival. A team at the Children’s Hospital of Philadelphia, led by Alan Flake, is the closest to human trials — their device is a bag filled with sterile fluid, which contains the fetus and is connected to tubes providing oxygen and nutrition.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： New CMS data security rules will hurt Medicare, Medicaid research

explore

WSS

Surprise medical billing ban raises prices elsewhere

Weight loss drugs aren’t covered by Obamacare. That may change

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

FDA warns medical device makers about rise in fabricated data

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

hotspot

entertainment

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Opioid cravings were reduced by anti

What does generative AI mean for health care? We asked experts

Alabama frozen embryo ruling has major implications for IVF clinics

Continuity nursing helped my family in our darkest PICU moments

NIH study of ME/CFS points to clear biological hallmarks

After affirmative action ruling, medical educators look to 'holistic review'

Community Health Systems hospitals under DOJ investigation

At least 13 dead in Texas as scorching temps continue

Medicare inequities exacerbate Puerto Rico’s health disparities

knowledge

Alabama IVF ruling threatens families facing fatal genetic disease

Obamacare plans could cover weight loss drugs

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

New documents shed light on MD Anderson Cancer Institute feud

Why palliative psychiatry is worth discussing

PBM reform efforts get punted in Congress

hotspot

hotspot

explore

explore